Acellular Allograft Amniotic Membrane 

aril® is a room temperature stable allograft derived from human placental tissue collected from consenting donors. Post-decellularization & stabilization, aril® is packaged in a double pouch packaging system and subjected to low dose gamma irradiation. aril® is an allograft tissue intended for homologous use regulated by 21 CFR Part 1271 and Section 361 of the PHS Act.

aril® is configured as a precision-cut single layer of amnion shaped as an ellipse or disc. The configuration was selected and designed to maximize clinical usable surface area and limit necessary pre-operative manipulation of the graft. Seed Biotech, Inc. has shown a greater than 95% reduction in DNA using their proprietary decellularization process. [9] As a single layer of amnion, it is not necessary to emboss aril® as there is no side-specific orientation to the graft.  

Clinical Advantage

aril® offers the clinical advantage of being an acellular precision cut graft designed and produced under industry expert guidance for optimal safety, efficacy, and clinical practicality.

Medical Use

Amniotic membrane is a graft used to protect and jumpstart the healing of a wide range of orthopedic, surgical, ophthalmology, spinal, and wound-covering applications. [7] The anti-inflammatory and antimicrobial properties it exhibits are well-suited for use in ophthalmics. Amniotic membrane has been proven to reduce the formation of adhesions and scar tissue, as well as accelerate healing. [2,3,4,5,6,7,8] Seed Biotech® leverages the natural protection offered by amniotic membrane in its product, in combination with proprietary processing technology, to create an acellular allograft amniotic membrane with clinically proven safety and efficacy.